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Abstract
Germline mutations in the adenomatous polyposis coli (APC) gene are responsible for familial adenomatous polyposis (FAP),
an autosomal dominant hereditary predisposition to the development of multiple colorectal adenomas and of a broad
spectrum of extra-intestinal tumors. Moreover, somatic APC mutations play a rate-limiting and initiating role in the majority
of sporadic colorectal cancers. Notwithstanding its multifunctional nature, the main tumor suppressing activity of the APC
gene resides in its ability to regulate Wnt/b-catenin signaling. Notably, genotype–phenotype correlations have been
established at the APC gene between the length and stability of the truncated proteins encoded by different mutant alleles,
the corresponding levels of Wnt/b-catenin signaling activity they encode for, and the incidence and distribution of intestinal
and extra-intestinal tumors. Here, we report a novel mouse model, Apc1572T, obtained by targeting a truncated mutation at
codon 1572 in the endogenous Apc gene. This hypomorphic mutant allele results in intermediate levels of Wnt/b-catenin
signaling activation when compared with other Apc mutations associated with multifocal intestinal tumors.
Notwithstanding the constitutive nature of the mutation, Apc
+/1572T mice have no predisposition to intestinal cancer but
develop multifocal mammary adenocarcinomas and subsequent pulmonary metastases in both genders. The histology of
the Apc1572T primary mammary tumours is highly heterogeneous with luminal, myoepithelial, and squamous lineages and
is reminiscent of metaplastic carcinoma of the breast in humans. The striking phenotype of Apc
+/1572T mice suggests that
specific dosages of Wnt/b-catenin signaling activity differentially affect tissue homeostasis and initiate tumorigenesis in an
organ-specific fashion.
Citation: Gaspar C, Franken P, Molenaar L, Breukel C, van der Valk M, et al. (2009) A Targeted Constitutive Mutation in the Apc Tumor Suppressor Gene Underlies
Mammary But Not Intestinal Tumorigenesis. PLoS Genet 5(7): e1000547. doi:10.1371/journal.pgen.1000547
Editor: Roel Nusse, Stanford University School of Medicine, Howard Hughes Medical Institute, United States of America
Received March 25, 2009; Accepted June 1, 2009; Published July 3, 2009
Copyright:  2009 Gaspar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: These studies were supported by grants from the Dutch Cancer Society (EMCR 2001-2482), the Netherlands Organisation for Scientific Research (NWO/
Vici 016.036.636), the BSIK program of the Dutch Government grant 03038 (www.stemcells.nl), and the EU FP6 and FP7 consortia Migrating Cancer Stem Cells
program (MCSCs; www.mcscs.eu) and TuMIC (integrated concept of tumor metastasis (http://itgmv1.fzk.de/www/tumic/tumic_main.htm). The fundersh a dn o
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: r.fodde@erasmusmc.nl
Introduction
Epithelial malignancies such as colorectal and breast cancer are
thought to arise and progress towards malignancy due to
alterations in signal transduction pathways that regulate the
balance between self-renewal and differentiation in adult stem cell
compartments [1]. The canonical Wnt/b-catenin signal transduc-
tion pathway plays a rate-limiting role in embryonic and adult
stem cell renewal, and its aberrant activation is among the most
common signaling defect in human cancers [2]. Activation of the
canonical Wnt pathway leads to intracellular b-catenin stabiliza-
tion and its translocation to the nucleus where it interacts with
members of the Tcf/Lef family of transcription factors to
modulate the expression of specific Wnt target genes (http://
www.stanford.edu/ ˜rnusse/pathways/targets.html). In the gastro-
intestinal tract, Wnt/b-catenin signaling regulates stemness and
differentiation of epithelial cells along the crypt-villus axis [3,4].
Accordingly, truncating mutations in the APC tumor suppressor
gene, the main negative regulator of the Wnt/b-catenin pathway,
result in the constitutive activation of canonical Wnt signaling thus
affecting stem cell differentiation and trigger tumor formation in
the GI-tract and in other extra-intestinal tissues in a dosage-
dependent fashion in man and mouse [5–8].
The structure and distribution of b-catenin binding and
downregulating motifs along the APC tumor suppressor gene is
particularly suited to study the effects of specific dosages of
canonical Wnt signaling on the multiplicity and tissue-specific
distribution of the resulting tumors (Figure 1A). The vast majority
of APC mutations found in hereditary and sporadic colorectal
cancers are distributed in the 59 half of the gene and are predicted
to encode for stable truncated proteins encompassing up to 3 b-
catenin downregulating (20 a.a.) domains. Stable truncation of the
mouse Apc gene at codon 1638 as encoded by the Apc
1638T allele,
results in a protein retaining a sufficient number of functional
domains to ensure wild type b-catenin regulation, namely 3 of the
7 b-catenin down-regulating domains and one Axin-binding
SAMP repeat (Figure 1A) [9]. Apc
+/1638T animals are tumor-free
and even homozygous Apc
1638T/1638T mice are viable with no
PLoS Genetics | www.plosgenetics.org 1 July 2009 | Volume 5 | Issue 7 | e1000547apparent predisposition to tumorigenesis [9], in sharp contrast
with the marked tumor predisposition and embryonic lethality
characteristic of all Apc-mutant mouse models described to date in
hetero- and homozygosity, respectively [6]. Notably, Apc
1572T,a
targeted allele designed to truncate Apc immediately upstream of
the only SAMP (Ser-Ala-Met-Pro) repeat encompassed by
Apc
1638T (Figure 1A), is characterized by an intermediate level of
Wnt/b-catenin signaling activation, higher than wild type Apc and
Apc
1638T though significantly lower than other Apc targeted alleles
known to result in GI tract tumors [9]. Here, we show that
Apc
+/1572T mice are characterized by a striking predisposition to
multifocal mammary adenocarcinomas with no susceptibility to
intestinal adenomas.
Results
The Apc1572T allele results in intermediate Wnt/b-
catenin signaling levels and differentiation defects in
embryonic stem cells
To allow the biochemical and functional characterization of
the Wnt/b-catenin signaling defect encoded by the Apc1572T
allele [9], we established Apc
1572T/1572T embryonic stem (ES) cells
from pre-implantation blastocysts and compared them by Top-
FLASH reporter assays [10] with Apc
+/+, Apc
1638T/1638T, and
Apc
1638N/1638N ES lines [5] (Figure 1B). The results show that
Apc
1572T/1572T ES cells encode for intermediate Wnt/b-catenin
signaling levels, in between those characteristic of Apc
1638N/1638N
and Apc
1638T/1638T. The latter are in fact very close to those of wild
type (Apc
+/+) ES cells, as previously reported [9]. These differences
in Wnt/b-catenin signaling dosage are likely to result from
diminished efficiency of b-catenin downregulation by the
Apc1572T truncated protein due to the deletion of the only
Axin-binding SAMP domain encompassed by Apc1638T. Im-
muno-precipitation (IP) analysis of the Apc-bound b-catenin
fractions in the different Apc-mutant ES cell lines confirmed that,
when compared with wild type (Apc
+/+) cells, decreasing amounts
of Apc-bound b-catenin are observed in Apc
1638T/1638T,
Apc
1572T/1572T, and Apc
1638N/1638N ES cells (Figure 1C).
Previously, we showed that different levels of b-catenin signaling
affect the ability of mouse embryonic stem (ES) cells to
differentiate towards specific lineages in a dosage-dependent
fashion [5]. To address the same question for the Apc1572T
allele, we have subcutaneously injected undifferentiated
Apc
1572T/1572T ES cells into syngenic mice to induce formation
of teratomas, as previously described [5]. The differentiation
profiles of the Apc
1572T/1572T teratomas were then investigated by
histological and immuno-histochemical analysis, and compared
with those obtained with wild type (Apc
+/+) and other Apc-mutant
ES cells. In line with their intermediate level of constitutive Wnt/
b-catenin signaling activation, Apc
1572T/1572T teratomas show a
more heterogeneous spectrum of ecto-, meso-, and endodermal
lineages than Apc
1638N/1638N (characterized by a higher Top-
FLASH reporter activity; see Figure 1B), though still more limited
in their differentiation capacity than Apc
1638T/1638T (characterized
by TopFLASH reporter activity comparable with wild type ES
cells) (Figure 2E). In agreement with previous observations [5],
several differentiation types, namely neural, bone, cartilage and
ciliated epithelia were absent in Apc
1638N/1638N teratomas. In
particular, markers employed to identify neuroectodermal
lineages did not stain Apc
1638N/1638N sections, in contrast with
Apc
1572T/1572T teratomas where a limited but significant number of
the cells were GFAP positive. Differentiation to striated muscle
was also severely affected and detectable in only a minority of the
Apc
1638N/1638N sections [5], whereas all Apc
1572T/1572T teratomas
analyzed revealed positive myosin staining. Notably, among the
cell types positively identified in Apc
+/+ teratomas, mammary
epithelia were relatively more abundant in Apc
1572T sections, as
shown by the combined staining with SMA and CK8 and the
typical tissue architecture with luminal cells on top of a
myoepithelial basal layer (Figure 2A–2D and Figure 2F).
Hence, homozygous Apc
1572T ES cells are characterized by an
intermediate differentiation defect between Apc
1638N/1638N and
Apc
1638T/1638T, with an unusual enrichment in mammary
epithelial differentiation.
Homozygosity for Apc
1572T results in embryonic lethality
Apc
+/1572T mice were generated from two independent ES
clones previously obtained by targeting a hygromycin cassette at
codon 1572 of the endogenous mouse Apc gene [9]. To assess the
post-natal viability of Apc
1572T/1572T mice, heterozygous Apc
+/1572T
animals were interbred and four litters analyzed (n=18 mice).
None of the resulting animals was found to be homozygous for the
targeted allele (p=0.0034, x
2 test) indicating that the Apc
1572T
allele results in embryonic lethality, as previously observed for the
majority of Apc-mutant mouse models with the only exception of
Apc
1638T [6,9]. Thus, the difference between the Apc
1572T and
Apc
1638T truncated proteins, namely the Axin-binding SAMP
motif pinpoints to a key role for this functional domain in Wnt
signaling regulation during embryonic development.
Apc
+/1572T mice develop mammary adenocarcinomas
encompassing heterogeneous cell lineages
Phenotypic analysis of Apc
+/1572T heterozygous animals was
performed on a total of 69 mice and compared with wild type,
Apc
+/1638N and Apc
+/Min on two different genetic backgrounds,
namely inbred C57Bl6/J and F1 C57Bl6/J6129Ola (Table 1). GI
tumor multiplicities and localization in Apc
+/Min and Apc
+/1638N
did not differ from previously published data [11,12]. Notably,
Apc
+/1572T mice do not have an increased susceptibility to
intestinal tumors when compared with wild type animals.
Author Summary
Although signal transduction pathways are often de-
scribed as ‘‘on–off’’ systems, the more quantitative aspects
of signalling are likely to represent a very important means
of regulation of the downstream biological outcomes.
Mutations in members of the canonical Wnt signaling
pathway represent among the most common defects in
human cancers. However, it is yet unclear which factors
determine tissue and organ specificity of the tumours
arising upon Wnt constitutive activation. Previously, we
have generated a series of hypomorphic alleles at the Apc
tumor suppressor gene and showed that the differentia-
tion potential of embryonic stem cells is dependent on the
dosage of Wnt/b-catenin signalling these mutants encode
for. Likewise, analysis of the two mutational hits occurring
at the Apc gene in human and mouse intestinal tumors
showed that these are selected to retain specific residual
dosages of b-catenin downregulation. Here, we provide
further support for this ‘‘just-right’’ signalling model by
targeting a germline Apc mutation encoding for very low
levels of Wnt signalling activation when compared with
other mutants known to trigger intestinal tumorigenesis.
Notwithstanding the constitutive nature of this mutation,
heterozygous mice show a remarkable and highly
penetrant predisposition to multifocal and metastatic
mammary cancers without the GI tract tumor phenotype
characteristic of the majority of Apc mouse models.
Specific Wnt Dosages Trigger Mammary Tumorigenesis
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model [12], were also observed among Apc
+/1572T mice with the
same gender-specific distribution though with diminished multi-
plicity and penetrance (Table 1).
Together with the absence of intestinal tumors, the most striking
phenotypic feature of the Apc
+/1572T mouse model is undoubtedly
represented by the highly penetrant incidence of multifocal
mammary tumors among virgin females (100%) and males
(30%), in sharp contrast with Apc
+/Min and Apc
+/1638N animals
(1/6 and 0/14, respectively) (Table 1, Figure 3A–3D). These
tumors typically arise around 3 months of age in C57BL6/J
animals, though age of onset fluctuates in the different genetic
backgrounds (Table 1). Histological analysis of the Apc
+/1572T
mammary tumors revealed a lobular arrangement with both
acinar and glandular growth patterns (Figure 4A). Varying degrees
of squamous metaplasia were observed in all tumors analyzed.
These structures resemble skin and hair follicle differentiation
(Figure 4B), in some cases strikingly similar to that observed in
trichoepithelioma originated from the hair follicle. This highly
heterogeneous histology with diffuse lobular hyperplasia and
Figure 1. Biochemical characterization of the targeted Apc1572T allele. (A) Schematic representation of the APC tumor suppressor protein,
its functional domains, and the truncated proteins resulting from the Apc1572T, Apc1638N, and Apc1638T targeted alleles. Only residual amounts
(2%) of the truncated Apc1638N protein are encoded by the targeted allele, as shown by immuno-precipitation analysis of Apc
1638N/1638N ES lines [5].
(B) b-catenin/TCF reporter assay (TOP-FLASH) analysis of Apc
+/+ (1) and Apc-mutant ES cell lines: Apc
1638T/1638T (2); Apc
1572T/1572T (3); Apc
1638N/1638N (4).
Each bar represents the average measurement of the luciferase units from triplicate assays. For each cell line, 3 independent experiments were
performed with the TOP (filled bars) and FOP (empty bars) reporter constructs. The bold figures represent the average TOP/FOP ratio of all
independent experiments. Depicted error bars correspond to standard deviation. In brief, ES cells were plated on dishes coated with MEFs and
subsequently transfected by lipofection with either the TOP-FLASH or FOP-FLASH reporter constructs [10] together with the Renilla luciferase vector
for normalization purposes. (C) Immuno-precipitation (IP) analysis of Apc-bound b-catenin in Apc-mutant ES cell lines. For comparative purposes,
immuno-precipitates obtained from equal amounts of total cellular lysates were loaded.
doi:10.1371/journal.pgen.1000547.g001
Specific Wnt Dosages Trigger Mammary Tumorigenesis
PLoS Genetics | www.plosgenetics.org 3 July 2009 | Volume 5 | Issue 7 | e1000547Figure 2. Teratoma formation assays indicate an intermediate differentiation defect in Apc
1572T/1572T ES cells. (A) HE analysis of normal
mammary gland with luminal cells surrounded by a basal layer of myoepithelial cells. (B) IF analysis of normal mammary glands for Ck8 (luminal cells,
green) and Sma (myoepithelial, red). (C) HE staining of Apc
1572T/1572T teratoma showing the typical mammary gland architecture with lobular and
ductal structures. (D) IF analysis of Apc
1572T/1572T teratomas for luminal and myoepithelial cell types. The frequency of these structures in teratomas
derived from Apc
1572T/1572T ES cells is largely increased when compared with (F) teratomas derived from Apc
+/+ ES cells. (E) Summary of the results of
the teratoma differentiation assays of Apc-mutant ES cells. Antibodies employed to evaluate differentiation are: Glial Fibrillary Acidic Protein (GFAP)
for glial cells; 2H3 for neurofilaments; SV2 for synaptic vesicles; A4.1025 for adult myosin. Mammary gland structures were primarily identified by HE
and then confirmed by IF as shown in panels a–d; also in the case of cartilage and epithelial structures HE stained section were employed. n.d. not
determined. Differentiation levels were scored as: (2) not present; (2*) vestigial presence; (+) present; (++) highly abundant. The shaded areas
indicate groups of teratomas for which the corresponding antibody staining was negative.
doi:10.1371/journal.pgen.1000547.g002
Specific Wnt Dosages Trigger Mammary Tumorigenesis
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PLoS Genetics | www.plosgenetics.org 5 July 2009 | Volume 5 | Issue 7 | e1000547Figure 3. Phenotypic characterization of Apc
+/1572T mice: mammary adenocarcinomas are composed by mixed differentiation
lineages with heterogeneous patterns of b-catenin intracellular accumulation and subcellular localization. Survival curves of (A) female
and (B) male Apc
+/1572T mice, respectively. The black, green and red lines are representative of mice in the 129Ola, F1 B6x129Ola, and B6 respectively.
Please note that in these graphs, age of death represents the moment at which, due to the presence of signs of discomfort or because the tumor size
exceeded 2 cm
3, mice had to be euthanized according to institutional and national regulations. (C) Macroscopic image of the appearance of the
mammary adenocarcinomas characteristic of the Apc1572T model. (D) Examples of global digital microscopy scans of two mammary
adenocarcinomas from Apc
+/1572T mice illustrative of the multi-lineage nature of these lesions.
doi:10.1371/journal.pgen.1000547.g003
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PLoS Genetics | www.plosgenetics.org 6 July 2009 | Volume 5 | Issue 7 | e1000547Figure 4. Differentiation. HE staining of mammary tumors (A–B) and pulmonary metastases (C) from Apc
+/1572T mice shows typical mammary
glandular architecture and squamous differentiation. (D–F) Luminal epithelial differentiation as shown by cytokeratin 8 (Ck8) IHC staining. (G–I)
Myoepithelial differentiation revealed by IHC staining with the Sma antibody. (J–L) IHC analysis with antibodies directed against cytokeratin 14 (Ck14)
confirm the presence of squamous differentiation (hair follicle and skin cellular types). (M–O) b-catenin IHC analysis shows heterogeneous subcellular
localization and intracellular accumulation with fewer cells characterized by positive nuclear staining. The results shown in this figure were confirmed
in 12 independent primary tumors.
doi:10.1371/journal.pgen.1000547.g004
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smaller lesions. Thus, trans-differentiation of mammary epithelial
cells takes place at an early stage during Apc–driven tumorigenesis.
Immunohistochemistry (IHC) analysis revealed that all Apc
+/1572T
mammary adenocarcinomas (n=12) encompass luminal and
myoepithelial cell types together with areas of squamous
metaplasia (Figure 4D–4E, Figure 4G–4H, and Figure 4J–4K).
Heterogeneous patterns of b-catenin subcellular localization were
also observed upon IHC analysis of Apc
+/1572T mammary tumors
with the majority of parenchymal cells showing membrane-bound
and cytoplasmatic staining along with smaller patches character-
ized by strong nuclear staining (Figure 4M–4N).
As observed in the vast majority of the intestinal and extra-
intestinal tumors caused by APC gene mutations in man and mouse,
LOH analysis of DNA and protein samples from Apc
+/1572T
mammary tumors revealed allelic imbalance in more than 90% of
cases (21/23) (Figure 5A). These observations were validated by
western analysis of tumor-derived cell lysates (Figure 5B).
During necropsy, Apc
+/1572T mice were identified with gross
pulmonary alterations subsequently identified as metastases of the
primary mammary adenocarcinomas by histological and IHC
analysis. Similar to the primary mammary carcinomas, these
lesions encompassed both luminal and myoepithelial cell types
(Figure 4C, 4F, and 4I). Areas of squamous differentiation were
also present, though significantly less abundant than in the
primary mammary tumors (Figure 4L). b-catenin IHC analysis of
the Apc
+/1572T lung metastases recapitulated the staining pattern of
the primary tumors (Figure 4O).
Figure 5. LOH analysis of Apc
+/1572T mammary adenocarcinomas. (A) PCR–based LOH analysis of tumour DNA samples amplified in the
presence of radioactive nucleotides as previously described [35]. Samples were scored as having lost the wild type allele when the ratio between the
intensity of the two alleles was #0.6. Apc
+/1572T mammary tumor samples (T); Apc
+/+ DNA control (C1); Apc
+/1572T DNA control (C2). Out of the 27
samples (collected from 23 tumours) analysed, only two (lanes marked by an asterisks) show a ratio higher than 0.6 and were accordingly scored as
not having allelic imbalance. (B) Western analysis of tumour-derived total protein lysates confirms the somatic loss of full length Apc. Tumour samples
(T); wild type control (C3); Apc
+/1572T control from tail sample (C4).
doi:10.1371/journal.pgen.1000547.g005
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+/1572T/Smad4
+/Sad mice regain predisposition to
intestinal tumors
To provide additional experimental support for the ‘‘just right’’
signaling model for Apc-driven mammary tumorigenesis, we have
taken advantage of a recent study according to which Tgf-b
signaling antagonizes canonical Wnt signaling thus negatively
regulating stem cell self-renewal [13]. Hence, Tgf-b alterations
such as those resulting from Smad4 loss of function mutations, are
expected to lead to a further increase of Wnt/b-catenin signaling
in the Apc-mutant cellular background. Therefore, we have bred
Apc
+/1572T animals with Smad4
+/Sad, a mouse model for juvenile
polyposis previously developed in our laboratory [14]. Smad4
+/Sad
animals are characterized by a late-onset predisposition to
hyperplastic intestinal polyps which develop in the absence of a
2
nd hit at either the Smad4 or the Apc locus [15]. As both these
tumor suppressor genes map to chromosome 18 in the mouse, we
have generated Apc
+/1572T/Smad4
+/Sad compound heterozygous
mice where both targeted alleles are in the in cis phase on chr. 18
as previously described for the Apc1638N model [15]. As shown in
Figure 6A, Apc
+/1572T/Smad4
+/Sad mice show a similar incidence of
mammary adenocarcinomas similarly to Apc
+/1572T, but are
characterized by multiple GI-tract tumors. These polyps are of
the adenomatous type and become apparent at a much earlier age
than the hyperplastic lesions with a pronounced stromal
component characteristic of the Smad4
+/Sad model (Figure 6B).
Moreover, the vast majority of the Apc
+/1572T/Smad4
+/Sad
intestinal polyps show loss of the entire chr. 18 carrying the wild
type alleles of both tumor suppressor genes [15] (Figure 6C),
whereas the intestinal lesions characteristic of the Smad4
+/Sad mice
retain the wild type Smad4 allele at first, and show Smad4 LOH (but
not at the Apc locus) only at more advanced progression stages
[15]. Although it cannot be excluded that loss of Smad4 function
underlies intestinal tumour formation in these animals through
Tgf-b/BMP downstream effectors independent of Wnt signaling,
the histology and molecular features of the Apc
+/1572T/Smad4
+/Sad
GI polyps strongly suggest that the further increase of Wnt/b-
catenin signaling conferred by the Smad4 mutation in the
Apc-mutant background results in intestinal tumours in the
compound mice without apparently affecting the mammary
cancer phenotype.
Discussion
Although the role of Wnt/b-catenin signalling has been
established for a broad spectrum of cancers [2], it is yet unclear
which factors determine tissue and organ specificity of the tumors
arising upon its constitutive activation. In familial adenomatous
polyposis (FAP) for example, different APC germline mutations
lead to different spectra of extra-colonic manifestations depending
on their localization along the gene and on the stability of the
resulting truncated polypeptide [16,17]. In general, it appears that
more hypomorhic APC mutants localized at the 59 and 39 ends of
the gene result in atypical FAP phenotypes characterized by
reduced intestinal adenoma multiplicities and enhanced tumori-
genesis outside the GI tract (mainly desmoids and cutaneous cysts)
[18]. Here, we show that a hypomorphic mutation in the mouse
Apc tumour suppressor gene results in a highly penetrant
predisposition to mammary adenocarcinomas without the intes-
tinal tumours characteristic of FAP patients carrying germline APC
mutations and of most Apc-mutant mouse models reported to date
[6]. This unique tumor phenotype is even more accentuated by
the presence of pulmonary metastases arising from the primary
mammary lesions, a feature rarely observed in genetically modified
mouse models of epithelial malignancies.
Notably, DU4475, a human breast cancer cell line derived from
a recurrent thoracic wall tumor following mastectomy due to a
poorly differentiated invasive ductal carcinoma [19], carries a
nonsense mutation at codon 1577 of the APC gene, only 5 residues
downstream of the targeted Apc1572T allele [20,21]. Hence, it is
plausible to think that only very specific alterations result in the
‘‘just right’’ level of Wnt/b-catenin signaling activation and trigger
neoplastic transformation in the mammary gland, presumably by
affecting self-renewal of the stem cell population as shown by the
observed metaplastic changes. In this hypothetical model, the
critical Wnt signalling threshold level to ensure stem cell
homeostasis, i.e. the equilibrium between self-renewal and
differentiation, is considerably lower in the mammary gland than
in the intestinal epithelium. However, this would imply that most
Apc-mutant mouse models, characterized by a pronounced
predisposition to multiple intestinal tumors [6], should also be
susceptible to mammary tumorigenesis. Indeed, most targeted Apc
models show predisposition to mammary adenocarcinomas,
though with considerably less penetrance than the GI tract tumors
[22–24]. More importantly, transplantation of mammary glands
from Apc
+/Min mice into wild type recipient animals results in
metaplastic adenocarcinomas [22], thus showing that the propen-
sity to develop mammary tumors is intrinsic to the Apc-mutant
cells.
Further confirmation of the validity of the ‘‘just right’’ signaling
model has been more recently provided by the conditional
inactivation of both Apc alleles in the lactating mammary gland
cells (by BLG-Cre) which resulted in multiple metaplastic growths
which do not progress to neoplasia [25]. Even more support for
the ‘‘just right’’ signaling hypothesis has been delivered by the
study by Kuraguchi et al. where the conditional loss of a single
Apc-LoxP allele is specifically driven in mammary progenitor cells
(by K14-Cre) and in lactating luminal cells (by WAP-Cre) [26]. Only
the K14-Cre-mediated Apc heterozygosity resulted into mammary
adenocarcinomas with similar histological features to those
observed in Apc
+/1572T tumors, thus suggesting the early progenitor
or stem cell of origin of these mixed lineage tumors. Notably,
analysis of the wild type Apc allele in the K14-Cre;Apc
+/CKO
mammary tumors revealed the presence of specific somatic point
mutations clustering in the codon 1521–1570 region, i.e. very close
to residue 1572 where our own mutation was targeted [26]. Thus,
the genetic mechanisms underlying Apc-mediated mammary
tumor formation are strikingly similar between the tissue specific
conditional knock-out K14-Cre;Apc
+/CKO model and the constitu-
tive Apc
+/1572T mice: in both cases one allele is completely lost (the
germline conditional KO allele in K14-Cre;Apc
+/CKO and the
somatic loss in Apc
+/1572T) whereas the other retains residual b-
catenin downregulating activity (the somatic point mutations
found in K14-Cre;Apc
+/CKO, and the targeted germline mutation in
Apc
+/1572T). The final outcome of these selection processes is the
retention of the dosage of Wnt/b-catenin signaling that is ‘‘just
right’ to allow clonal expansion of mammary stem cells or early
progenitors and their neoplastic transformation.
A second implication of the ‘‘just right’’ signalling model is that
an increase of the Wnt/b-catenin signaling dosage conferred by
the Apc1572T mutation is expected to trigger intestinal tumor
formation. Recently, it has been reported that Tgf-b signaling
antagonizes canonical Wnt thus negatively regulating stem cell
self-renewal [13]. Hence, Tgf-b alterations such as those resulting
from Smad4 loss of function mutations, are expected to lead to a
further increase of Wnt/b-catenin signaling in the Apc-mutant
cellular background. Accordingly, Apc
+/1572T/Smad4
+/Sad com-
pound heterozygous mice revealed a similar incidence of
mammary adenocarcinomas as in Apc
+/1572T, but were also
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PLoS Genetics | www.plosgenetics.org 9 July 2009 | Volume 5 | Issue 7 | e1000547Figure 6. Phenotypic and molecular analysis of the compound in cis Apc
+/1572T/Smad4
+/Sad mouse model. (A) Schematic illustration of the
chr. 18 LOH event in intestinal tumors from in cis Apc
+/1572T/Smad4
+/Sad mice leading to loss of both Smad4 and Apc wild-type alleles. (B) Comparative
phenotypic analysis of the intestinal and mammary tumor predisposition among Apc
+/1572T, Smad4
+/Sad, and Apc
+/1572T/Smad4
+/Sad mice. Notes: (1)
The incidence of GI tumors was calculated after exclusion of the pyloric lesions as these present in clusters often difficult to count. (2) The multiplicity
of GI tumors was calculated based on all animals with the exception of those where the high tumor burden made the count not feasible. The asterisks
indicate that the apparent absence of intestinal tumor in Smad4
+/Sad control animals is not in contradiction with what previously published. These
mice were sacrificed at time points matched with the ages at which compound Apc
+/1572T/Smad4
+/Sad mice had to be sacrificed due to the high GI
and mammary tumor burden (R: 90.4 days +/228.4; =: 118.5 days +/226.2). However, in Smad4
+/Sad animals the majority of the tumors appear at 9
months of age [15]. (C) H&E staining of intestinal tumor sections from Apc
+/1572T (top), Apc
+/1572T/Smad4
+/Sad (middle), and Smad4
+/Sad (bottom) mice.
(D) Smad4 IHC analysis of two intestinal adenomas from Apc
+/1572T/Smad4
+/Sad mice showing loss of Smad4 expression. LOH was observed in 100% of
the polyps (n=15) analyzed. PCR–based LOH analysis of the same cohort of Apc
+/1572T/Smad4
+/Sad polyps revealed loss of wild-type Apc allele in 87%
of the cases (13/15; data not shown).
doi:10.1371/journal.pgen.1000547.g006
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parental strain, even when kept for longer than 1 year. These
polyps arise from loss of the entire mouse chr. 18 where both the
Apc and Smad4 tumor suppressor genes map, and are clearly
different from the hyperplastic lesions characteristic of Smad4
+/Sad
mice which retain the wild type Smad4 allele [15]. Although it
cannot be excluded that loss of Smad4 function underlies intestinal
tumour formation in these animals through Tgf-b/BMP down-
stream effectors independent of Wnt signaling, the histology and
molecular features of the Apc
+/1572T/Smad4
+/Sad GI polyps
strongly suggest that the further increase of Wnt/b-catenin
signaling conferred by the Smad4 mutation in the Apc-mutant
background results in the observed predisposition to intestinal
tumours in the compound mice without apparently affecting the
mammary cancer phenotype.
In view of the well known multifunctional nature of the APC
tumor suppressor protein [27], one could also envisage that
functional motifs other that those binding and downregulating b-
catenin and Axin, could underlie the striking tumor phenotype of
the Apc1572T model. However, with the only exception of the
SAMP motif, all the known functional domains located in the
COOH third of the protein which are truncated by the targeted
mutation at codon 1572 are also absent in the Apc1638T model,
previously shown to be tumor free even when bred to
homozygosity [9].
Several members of the Wnt signaling cascade including the
Wnt1 ligand and b-catenin, have been shown to result in
mammary hyperplasia and tumors when overexpressed in
transgenic mice in a tissue-specific fashion [26,28–31]. Notably,
the MMTV-driven Wnt1 and b-catenin transgenic models
develop mammary metaplasia highly reminiscent of the tumors
observed in Apc
+/1572T animals, especially as far as the heteroge-
neity of their histology is concerned. Among the broad spectrum of
breast cancers observed in man, the histological subtype that most
closely resembles the Apc1572T mammary adenocarcinomas is
represented by metaplastic carcinoma of the squamous type,
responsible for 1 to 5% of the total breast cancer burden [32].
Notably, genetic alterations in different members of the Wnt
signaling pathway including CTNNB1 (b-catenin), APC, and
WISP3 (Wnt1 Induced Secreted Protein 3) are relatively common
among metaplastic carcinomas of the breast [33]. Hence, it is
plausible to think that only very specific gene alterations result in
the ‘‘just right’’ level of Wnt/b-catenin signaling activation to
trigger neoplastic transformation in the human mammary gland.
On the contrary to other, more common gene mutations leading
to breast cancer (e.g. ErbB2) which are likely to affect more
committed progenitor cells, Wnt/b-catenin signaling activation
presumably affects self-renewal and differentiation capacity of the
mammary primordial stem cell or in very early progenitors as
shown by the metaplastic changes and the presence of both
myoepithelial and luminal lineages in Wnt-driven mammary
tumors.
Apart from their resemblance with breast metaplastic carcino-
mas in man, the mammary adenocarcinomas observed in Apc
+/
1572T mice without the concomitant presence of multiple intestinal
polyps raise the possibility that a fraction of the hereditary breast
cancer cases could be caused by germline APC mutations located
in the proximity of codon 1572. We are currently testing this by
sequencing the APC gene around codons 1500–1700 in hereditary
breast cancer patients which tested negative for BRCA1/BRCA2
germline mutations. Also, we are searching whether FAP patients
with APC germline mutations in the proximity of codon 1600 show
any eventual predisposition to breast cancer. However, it is also
possible that mutations in other members of the Wnt pathway may
result in the ‘‘just right’’ signaling level and in tumor predispo-
sitions similar to the Apc1572T model.
In conclusion, we have shown that a targeted Apc mutation
encoding for intermediate levels of Wnt/b-catenin signaling results
in a highly penetrant predisposition to multifocal mammary
adenocarcinomas without the intestinal tumors characteristic of
most Apc-mutant mouse models and individuals carrying germline
APC mutations. Our results, also supported by several mammary
cancer studies in mouse and man suggests that only specific
dosages of canonical Wnt signaling are ‘‘just right’’ to expand the
mammary stem/progenitor cell and result into mixed lineage
(metaplastic) tumorigenesis.
Materials and Methods
Mouse strains
Apc
+/1572T mice were generated from two independent 129Ola
ES clones targeted at codon 1572 as previously described [9].
Stable expression of the truncated protein encoded by the targeted
allele was confirmed by western blot analysis (not shown).
Chimeras were bred with 129Ola and C57Bl6/J animals to
generate inbred 129Ola, and F1 (C57Bl6/J6129Ola) Apc
+/1572T
mice. To generate inbred C57Bl6/J Apc
+/1572T mice, F1 (C57Bl6/
J6129Ola) animals were backcrossed to inbred C57Bl6/J mice for
at least 8 generations. Control Apc
1638N and Apc
Min animals were
generated by crossing inbred C57Bl6/J mutants with 129Ola for
comparative purposes. Heterozygous mice were employed for the
phenotypic characterization, together with wild type littermates as
controls. Compound Apc
+/1572T/Smad4
+/Sad in cis mice were
generated as previously described [15].
All animals were fed ad-libitum and housed in SPF facilities.
Animal experiments were performed according to institutional and
national regulations.
ES cell lines generation and teratoma differentiation
assays
Apc
1572T/1572T ES cells were derived from pre-implantation (3.5
dpc) blastocysts as previously described [34]. Teratomas were
obtained upon subcutaneous injection of 5610
6 cells into isogenic
mice.
b-catenin/TCF reporter assays
5610
5 ES cells were plated on dishes coated with MEFs (mouse
embryonic fibroblasts) and subsequently transfected by Lipofecta-
mine 2000 (Invitrogen) with either 500ng of the TOP-FLASH or
FOP-FLASH reporter constructs [10] together with 5ng of the
Renilla luciferase vector for normalization purposes. Luciferase
activity was measured by Dual–Luciferase Reporter Assay System
(Promega).
Immunoprecipitation (IP) and western analysis
Apc IP analysis was performed according to previously
published protocol [9] using the AFPN polyclonal antibody.
Detection of Apc and b-catenin in the destruction complex was
carried out by using the following antibodies: Apc Ab1 (OP44,
Oncogene), b-catenin (610154, BD Biosciences).
Immunohistochemistry (IHC) and immunofluorescence
Tissues were fixed in PFA (4%) and embedded in paraffin. Five
mm sections were mounted on slides stained by HE for routine
histology. Antibodies employed for IHC analysis include: b-
catenin (1:2000, 1247-1, Epitomics), Troma1 which recognizes a
Ck8 epitope (1:400, Hybridoma Bank), Sma (1:200, M0851,
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(1:5000, PRB-169P, Covance). The Ck6 and Ck14 antibodies are
employed to detect hair follicle and skin differentiation, respec-
tively. However, when employed at a lower dilution (1:1000), Ck6
also detects mammary epithelial cells. All IHC images presented
here were obtained with higher dilution (1:5000) aiming at the
identification of squamous differentiation lineages. The same
primary antibody dilutions were employed for IF analysis, rabbit
anti-rat-FITC (Sigma) and goat anti-mouse-A594 (Invitrogen)
were used for signal detection.
LOH analysis
LOH analysis for the Apc locus was performed as previously
described [35]. In brief, tumour sections were obtained from
Apc
+/1572T mammary adenonarcinomas and stained by HE.
Tumour areas were localized and microdissected by LCM (Laser
Capture Microdissection; Leica Microssystems), followed by DNA
isolation. PCR-amplified fragments were resolved in a denaturing
6% polyacrylamide gel, dried on paper and the number of counts
per allele was determined on a phosphor imager. Subsequently,
the number of counts of the larger allele was divided by the counts
of the smaller allele to obtain an allelic ratio. A mean allelic ratio
was calculated for at least five normal controls. This value was
used to generate a comparative ratio (CR) .1.0 by dividing the
tumor allelic ratio by the mean normal allelic ratio. In this way,
normalization of imbalances already observed in wild type controls
due to preferential amplification of a specific allele, is not
necessary. A CR $1.5 was interpreted as significant, i.e. indicative
of loss of the wild type allele.
These PCR-based observations were further confirmed by
western blot analysis. Mammary tumors and control tail tissue
samples were digested with Blendzyme3 (Roche Diagnostics) in
DMEM medium supplemented with gentamycin. Protein lysates,
separation and blotting were performed using the NuPage Gel
System (gel Tris-Acetate 3–8%) according to manufacturer’s
protocol (Invitrogen). Apc detection was accomplished using the
antibody Apc Ab1 (OP44, Oncogene).
LOH analysis for the Smad4 gene was carried out exclusively at
the protein level by IHC on tissue sections (1:100, sc-7966, Santa
Cruz). In this case, antigen retrieval was performed with Tris-
EDTA pH 8.0 and the signal was detected using Envision HRP-
ChemMate Kit (DAKO).
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